ABIG vs QLTY

ABIGBArgent Large Cap ETF

QLTYAGMO US Quality ETF

In short

ABIG Argent's 2025 ETF debut: an active large-cap portfolio built around businesses the manager judges durable, screened on growth, quality and value, at a fee under the typical active quality fund.

QLTY Most quality ETFs run a rules screen. QLTY hands the job to GMO's stock pickers, who buy US companies they judge high quality and chase plain total return. Active conviction, priced like it: 0.50% a year.

Stated mandate

ABIG The actively managed fund seeks long-term capital appreciation by investing in equity securities of large-capitalization companies that the sub-adviser considers high-quality, enduring businesses.

QLTY The Fund seeks total return. It is actively managed and invests primarily in equities of U.S. companies that GMO believes are high quality.

Why people hold it

• ABIG Costs 0.49% a year, below the 0.57% median for its active quality large-cap peer group and level with the cheapest top-rated fund in that group (ABFL).
• No index to hug. A sub-adviser runs a proprietary quantitative screen across growth, quality and value, then holds large caps it considers enduring businesses.
• The portfolio does what the prospectus advertises: US large caps, quality tilt, no style drift into small caps or foreign names.
• Sits in the upper half of its quality and free-cash-flow peer cohort despite being the newest name in the room.

• QLTY Actively managed, not index-tracking. GMO's team chooses the US companies it considers high quality, under a straightforward total-return mandate instead of a published factor formula.
• GMO's read on quality leans toward wide moats and free cash flow, so the lineup can look meaningfully different from the index-built quality funds it sits beside.
• Opened in 2023 and already a multi-billion-dollar fund with moderate daily trading and a quarterly distribution schedule.
• The filings match the label: a standard 1940-Act fund holding US equities, screened on quality, no derivative wrapper or offshore complexity.

Worth knowing

• ABIG Launched in April 2025, so the track record is short and risk measures rest on limited history.
• Small asset base and thin trading, which tends to mean wider bid-ask spreads than the established funds in this lane.
• Index-based quality exposure runs far cheaper (PSET charges 0.15%), so the fee here is the price of a human making the calls.

• QLTY The 0.50% fee runs above the typical quality-cohort charge, and index-built rivals undercut it hard: QUAL at 0.15%, JQUA at 0.12%.
• No index to fall back on. Everything rides on GMO's stock selection, and the ETF's own record only starts in 2023.
• Mostly on that fee, it sits in the lower half of its US quality peer group even though it does the job its documents describe.

Full ABIG profile⁠

Full QLTY profile⁠